Latest Walter Reed Army Institute of Research Stories
The Department of Defense's WRAIR will study Lpath's anti-LPA antibody in the blast injury model of TBI SAN DIEGO, April 23, 2014 /PRNewswire/ -- Lpath, Inc.
Unhealing Ulcers Afflict Millions, Including U.S.
Two-year agreement will test company’s breakthrough technology in defending U.S.
An international collaboration of researchers from the U.S. Army Medical Research and Materiel Command (USAMRMC), Tunisia and France has demonstrated a high cure rate and remarkably few side effects in treating patients with cutaneous leishmaniasis (CL) with an investigational antibiotic cream.
- A serpent whose bite was fabled to produce intense thirst.